↓ Skip to main content

Cochrane Database of Systematic Reviews

Levetiracetam add‐on for drug‐resistant focal epilepsy: an updated Cochrane Review

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
156 Mendeley
Title
Levetiracetam add‐on for drug‐resistant focal epilepsy: an updated Cochrane Review
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd001901.pub2
Pubmed ID
Authors

Gashirai K Mbizvo, Pete Dixon, Jane L Hutton, Anthony G Marson

Abstract

Epilepsy is an important neurological condition and drug resistance in epilepsy is particularly common in individuals with focal seizures. In this review, we summarise the current evidence regarding a new antiepileptic drug, levetiracetam, when used as add-on treatment for controlling drug-resistant focal epilepsy. This is an update to a Cochrane Review that was originally published in 2001.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Italy 2 1%
United Kingdom 1 <1%
Canada 1 <1%
Unknown 150 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 36 23%
Researcher 22 14%
Student > Postgraduate 14 9%
Student > Ph. D. Student 13 8%
Other 12 8%
Other 29 19%
Unknown 30 19%
Readers by discipline Count As %
Medicine and Dentistry 61 39%
Nursing and Health Professions 13 8%
Psychology 12 8%
Neuroscience 9 6%
Agricultural and Biological Sciences 6 4%
Other 17 11%
Unknown 38 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2020.
All research outputs
#4,857,628
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,973
of 11,842 outputs
Outputs of similar age
#34,246
of 187,469 outputs
Outputs of similar age from Cochrane database of systematic reviews
#128
of 228 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.